BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38270957)

  • 1. Proinflammatory cytokines set the stage for cardiac damage.
    Ashour D; Ramos G
    Cardiovasc Res; 2024 Mar; 120(2):109-110. PubMed ID: 38270957
    [No Abstract]   [Full Text] [Related]  

  • 2. Proinflammatory cytokines driving cardiotoxicity in COVID-19.
    Colzani M; Bargehr J; Mescia F; Williams EC; Knight-Schrijver V; Lee J; Summers C; Mohorianu I; Smith KGC; Lyons PA; Sinha S
    Cardiovasc Res; 2024 Mar; 120(2):174-187. PubMed ID: 38041432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine Deteriorates Cisplatin-Induced Cardiotoxicity in Rats and Induces Dose-Dependent Cisplatin Chemoresistance in MCF-7 Human Breast Cancer Cells.
    El-Sheikh AAK; Khired Z
    Cardiovasc Toxicol; 2021 Jul; 21(7):553-562. PubMed ID: 33796943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity.
    Eiras S; Álvarez E; Brión M; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2020 Aug; 73(8):691-693. PubMed ID: 32493574
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis.
    Cau R; Solinas C; De Silva P; Lambertini M; Agostinetto E; Scartozzi M; Montisci R; Pontone G; Porcu M; Saba L
    Int J Cancer; 2022 Dec; 151(11):1860-1873. PubMed ID: 35730658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression.
    Khafaga AF; El-Sayed YS
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):59-70. PubMed ID: 29085977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigating neutrophil trafficking and cardiotoxicity with DS-IkL in a microphysiological system of a cytokine storm.
    Shirure VS; Yechikov S; Shergill BS; Dehghani T; Block AV; Sodhi H; Panitch A; George SC
    Lab Chip; 2023 Jun; 23(13):3050-3061. PubMed ID: 37278194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
    Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective Effects of Octreotide against Sepsis-Induced Cardiotoxicity in Mice.
    Zigam QA; Al-Zubaidy AA; Abbas WJ; Al-Mudhafar RH
    Arch Razi Inst; 2023 Feb; 78(1):53-61. PubMed ID: 37312717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell-derived cardiomyocytes.
    Kwok M; Lee C; Li HS; Deng R; Tsoi C; Ding Q; Tsang SY; Leung KT; Yan BP; Poon EN
    Cardiovasc Res; 2022 Sep; 118(12):2652-2664. PubMed ID: 34609482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difenoconazole causes cardiotoxicity in common carp (Cyprinus carpio): Involvement of oxidative stress, inflammation, apoptosis and autophagy.
    Wang J; Gao X; Liu F; FangWang ; Dong J; Zhao P
    Chemosphere; 2022 Nov; 306():135562. PubMed ID: 35792209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity.
    Bhagat A; Shrestha P; Kleinerman ES
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cardiotoxicity-eliminated ACE2 variant as a pan-inhibitor against coronavirus cell invasion.
    Feng H; Yang L; Yang H; Cheng D; Li M; Song E; Xu T
    Mol Ther; 2024 Jan; 32(1):218-226. PubMed ID: 37974399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation.
    Sangomla S; Saifi MA; Khurana A; Godugu C
    J Trace Elem Med Biol; 2018 May; 47():53-62. PubMed ID: 29544808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs.
    Yu WL; Toh HS; Liao CT; Chang WT
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):205-214. PubMed ID: 32557011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fostering experimental and computational synergy to modulate hyperinflammation.
    Potapov I; Kanneganti TD; Del Sol A
    Trends Immunol; 2022 Jan; 43(1):4-7. PubMed ID: 34844849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-9 aggravates doxorubicin-induced cardiotoxicity by promoting inflammation and apoptosis in mice.
    Ye D; Wang Z; Xu Y; Ye J; Wang M; Liu J; Zhang J; Zhao M; Chen J; Wan J
    Life Sci; 2020 Aug; 255():117844. PubMed ID: 32464124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity.
    Pecoraro M; Del Pizzo M; Marzocco S; Sorrentino R; Ciccarelli M; Iaccarino G; Pinto A; Popolo A
    Toxicol Appl Pharmacol; 2016 Feb; 293():44-52. PubMed ID: 26780402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
    Zhu W; Reuter S; Field LJ
    Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.